This company listing is no longer active
このページの翻訳は実験的なもので、現在開発中です。お待ちしております
Biodexa Pharmaceuticals 過去の業績
過去 基準チェック /06
Biodexa Pharmaceuticals has been growing earnings at an average annual rate of 4.3%, while the Biotechs industry saw earnings growing at 12.5% annually. Revenues have been declining at an average rate of 14% per year.
主要情報
4.3%
収益成長率
61.2%
EPS成長率
| Biotechs 業界の成長 | -14.6% |
| 収益成長率 | -14.0% |
| 株主資本利益率 | -71.6% |
| ネット・マージン | -832.1% |
| 前回の決算情報 | 30 Jun 2022 |
最近の業績更新
Recent updates
収支内訳
Biodexa Pharmaceuticals の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。
収益と収入の歴史
| 日付 | 収益 | 収益 | G+A経費 | 研究開発費 |
|---|---|---|---|---|
| 30 Jun 22 | 1 | -5 | 3 | 0 |
| 31 Mar 22 | 1 | -5 | 3 | 0 |
| 31 Dec 21 | 1 | -5 | 3 | 0 |
| 30 Sep 21 | 1 | -7 | 3 | 2 |
| 30 Jun 21 | 1 | -8 | 3 | 2 |
| 31 Mar 21 | 0 | -15 | 4 | 1 |
| 31 Dec 20 | 0 | -22 | 4 | 0 |
| 30 Jun 20 | 0 | -22 | 5 | 0 |
| 31 Mar 20 | 1 | -16 | 5 | 0 |
| 31 Dec 19 | 1 | -9 | 4 | 0 |
| 30 Jun 19 | 2 | -9 | 4 | 0 |
| 31 Mar 19 | 2 | -10 | 4 | 0 |
| 31 Dec 18 | 2 | -10 | 4 | 0 |
| 30 Jun 18 | 1 | -11 | 4 | 0 |
| 31 Mar 18 | 1 | -11 | 4 | 0 |
| 31 Dec 17 | 1 | -12 | 4 | 0 |
| 30 Sep 17 | -3 | -1 | -7 | -5 |
| 30 Jun 17 | 4 | -18 | 10 | 6 |
| 31 Mar 17 | 6 | -19 | 14 | 7 |
| 31 Dec 16 | 1 | -6 | 3 | 0 |
| 30 Sep 16 | 5 | -17 | 12 | 10 |
| 30 Jun 16 | 4 | -13 | 13 | 6 |
質の高い収益: 5MP0 is currently unprofitable.
利益率の向上: 5MP0 is currently unprofitable.
フリー・キャッシュフローと収益の比較
過去の収益成長分析
収益動向: 5MP0 is unprofitable, but has reduced losses over the past 5 years at a rate of 4.3% per year.
成長の加速: Unable to compare 5MP0's earnings growth over the past year to its 5-year average as it is currently unprofitable
収益対業界: 5MP0 is unprofitable, making it difficult to compare its past year earnings growth to the Biotechs industry (-17.2%).
株主資本利益率
高いROE: 5MP0 has a negative Return on Equity (-71.65%), as it is currently unprofitable.